In the ever-evolving landscape of healthcare, the InVitro Diagnostics (IVD) manufacturers market plays a pivotal role in delivering precise diagnostic solutions. As the demand for accurate and rapid diagnostic tests continues to soar, IVD manufacturers are entrusted with meeting the growing expectations of their clients. This professional editorial delves into the intricate dynamics of the IVD manufacturers market, shedding light on the unique challenges faced by these industry players and exploring how they strive to surpass client expectations with unwavering precision and unmatched commitment to quality.
Speaking of one competent player in the IVD space, Pariksha Biotech is a private limited company specializing in the manufacturing and marketing of in vitro diagnostic reagents and medical devices. The company started manufacturing general clinical chemistry reagents and later introduced an innovative specialized product line in the areas of Clinical Chemistry, Latex Enhanced Turbidimetric Immunoassays (LETIA), Clinical Microbiology, Serology, Coagulation, and Rapid Tests. The quality of Pariksha’s products is unmatchable as the company always innovates in the production processes, stringent quality analysis, documentation, and services.
In an exclusive interview with Pariksha Biotech, we delve into the company’s inception story, core values, flagship offerings, unique strategies, leveraging technology, and future growth plans.
How has Pariksha Biotech positioned itself in the Indian market?
Pariksha Biotech has carved a niche for itself as a specialist in the field. Over the past two years, the company has made significant progress by introducing numerous new products that have been well-received by customers. Their focus on product quality has propelled them to be one of the most trustworthy names in the market today.
How has the market for in vitro diagnostics developed, and what factors have contributed to its growth?
The market for in vitro diagnostics has experienced notable growth, particularly due to the impact of COVID-19. The sudden recognition of the importance of diagnostic testing during the pandemic has led to increased awareness and support from government authorities and healthcare providers. Diagnostic tests have become a crucial step in patient care, as doctors now require accurate diagnoses before prescribing treatments. The industry has gained recognition from various stakeholders, including bankers and economists, who now appreciate its significance. Additionally, research and development efforts have resulted in the introduction of new diagnostic tools and regulations, further driving market growth.
What are the expectations and challenges from clients in the industry, and how has Pariksha Biotech met these expectations?
Clients in the industry expect fast and accurate diagnoses for diseases, enabling early treatment. They also seek affordability, ensuring that diagnostic tests are accessible to all, including the economically disadvantaged. Pariksha Biotech has been proactive in meeting these expectations by providing specialized diagnostic tools and medical devices at affordable prices. The company positions itself as a specialty diagnostic medical device provider and offers both regular and specialty diagnostic tests to fulfill market needs. By aligning with the dynamic requirements of the market and pre-empting customer demands, the company has successfully met client expectations.
How does Pariksha Biotech ensure quality standards while balancing cost-effectiveness?
Pariksha Biotech places a strong emphasis on maintaining quality standards. With a belief that quality is a foundation for success, the company ensures that its indigenously manufactured products undergo stringent quality control measures. They employ third-party quality control criteria and adhere to international quality standards. Real-time and stress studies are conducted on every batch to ensure quality consistency throughout the product’s shelf life. Pariksha Biotech even goes beyond the expiry date to demonstrate the longevity and reliability of its products. This commitment to quality is essential, particularly in a cost-sensitive country like India.
Pariksha Biotech is dedicated to developing & manufacturing high-quality goods that not only meet but significantly surpass market & customer experience standards
How does Pariksha Biotech engage with clients and ensure their understanding of the products?
Pariksha Biotech employs a comprehensive client engagement process, starting from understanding customer requirements to delivering training sessions. The company actively engages with doctors and pathologists, conceptualizing product ideas based on their input. They organize continuous medical education (CME) programs to enrich the knowledge of healthcare professionals about the latest diagnostic tools. Pariksha Biotech also conducts demonstrations to showcase their products and their practical applications. These efforts aim to facilitate effective communication and promote their products to the target audience.
Could you provide insights into the experienced team behind Pariksha Biotech’s success?
Pariksha Biotech boasts a team of seasoned professionals who have demonstrated their expertise in the industry. With a combined experience of over 35 years, the team has a deep understanding of the market dynamics. They possess technical knowledge coupled with sales and marketing skills, enabling them to effectively sell and promote more of its quality-driven products. The company has a robust sales force, management team, and technical team working cohesively to drive sales and marketing efforts. The team’s knowledge, drive, and market awareness contribute significantly to the company’s success.
What are the expansion plans for Pariksha Biotech in the future?
Pariksha Biotech aims to expand exponentially by introducing new products and diversifying into instrumentation, analyzers, testing products, and medical devices. The company intends to make its presence felt in these fields.
C. Anil Kumar, President
Anil, President by designation is the helmer of Pariksha Biotech who is a Post Graduate in Microbiology and has 35 years of rich experience in various fields like Biotechnology, Immunology, Invitro Diagnostics, and Cellular & Molecular Biology. Having worked for three Indian Pharma Majors and Four Diagnostic biggies and having acquired massive experience Anil Kumar is pretty confident to take the company to the heights in the years to come with the support of his incredible administration and marketing teams.
We use cookies to ensure you get the best experience on our website. Read more...
.jpg "Technology in Cancer Care: A story of evolving paradigms")
.jpg "Bringing Shop Floor to Manufacturer's palm: Smart Factory Solutions for tomorrow")
